Enaltec Pharma Research Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 24-10-2024
- Paid Up Capital ₹ 1.40 M
as on 24-10-2024
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 14.68 Cr
as on 24-10-2024
- Satisfied Charges ₹ 34.17 Cr
as on 24-10-2024
- Revenue -47.24%
(FY 2023)
- Profit -41.23%
(FY 2023)
- Ebitda -576.12%
(FY 2023)
- Net Worth -27.74%
(FY 2023)
- Total Assets 2.75%
(FY 2023)
About Enaltec Pharma Research
The Corporate was formerly known as Getz Pharma Research Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.40 M.
The company currently has active open charges totaling ₹14.68 Cr. The company has closed loans amounting to ₹34.17 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anand Shah, Amit Jain, Samir Kumar, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24230MH2005PTC153404
- Company No.
153404
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 May 2005
- Date of AGM
24 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Enaltec Pharma Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Shah  | Managing Director | 18-May-2005 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sumit Gupta | Nominee Director | 30-Mar-2017 | Current |
| Neeraj Singh | Nominee Director | 06-May-2023 | Current |
| Amit Jain | Nominee Director | 14-Feb-2022 | Current |
| Samir Kumar | Nominee Director | 14-Feb-2022 | Current |
| Vivek Gupta | Nominee Director | 14-Feb-2022 | Current |
Financial Performance and Corporate Structure Insights of Enaltec Pharma Research.
Enaltec Pharma Research Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 47.24% decrease. The company also saw a substantial fall in profitability, with a 41.23% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Enaltec Pharma Research?
In 2023, Enaltec Pharma Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
La Renon Healthcare Private LimitedActive 17 years 4 monthsSamir Kumar and Vivek Gupta are mutual person
Enaltec Labs Private LimitedActive 18 years 9 monthsAnand Shah, Amit Jain and 3 more are mutual person
Genlink Pharma Solutions Private LimitedActive 8 years 7 monthsAnand Shah and Sumit Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 Oct 2020 | ₹1.18 Cr | Open |
Hdfc Bank Limited Creation Date: 16 Mar 2018 | ₹10.00 Cr | Open |
Hdfc Bank Limited Creation Date: 16 Mar 2018 | ₹3.50 Cr | Open |
How Many Employees Work at Enaltec Pharma Research?
Enaltec Pharma Research has a workforce of 40 employees as of Sep 17, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Enaltec Pharma Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enaltec Pharma Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
